Treatment of experimental adjuvant arthritis with the combination of methotrexate and lyophilized Enterococcus faecium enriched with organic selenium

. 2002 ; 47 (5) : 573-8.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid12503406

The efficacy of combination therapy with methotrexate (MTX) and probiotic bacteria Enterococcus faecium enriched with organic selenium (EFSe) in rats with adjuvant arthritis was determined. Rats with adjuvant arthritis were given MTX (0.3 mg/kg 2-times weekly, orally); lyophilized E. faecium enriched with Se (15 mg/kg, 5 d per week, orally); and a combination of MTX plus EFSe for a period of 50 d from the immunization. Levels of serum albumin, serum nitrite/nitrate concentrations, changes in hind paw swelling, arthrogram score, bone erosions, whole body bone mineral density (BMD) and bone mineral content (BMC) were assayed in the rats as variables of inflammation and destructive arthritis-associated changes. Treatment with MTX and with the combination MTX + EFSe significantly inhibited markers of both inflammation and arthritis. Significant differences in favor of combination therapy with MTX + EFSe as compared to MTX alone were seen in serum albumin concentration, hind paw swelling and arthrogram score. Reductions in radiographic scores were also more pronounced in the combination therapy group. Combination therapy, but not MTX alone, inhibited the reduction of BMD and BMC; treatment with lyophilized EFSe alone had no significant effect on adjuvant arthritis in rats. The potent therapeutic effect of low dosage MTX therapy in combination with lyophilized EFSe on adjuvant arthritis in rats was shown.

Zobrazit více v PubMed

J Bone Miner Res. 1993 Jun;8(6):659-68 PubMed

J Rheumatol. 1988 Aug;15(8):1193-7 PubMed

Am J Pathol. 1963 Jan;42:73-95 PubMed

Arthritis Rheum. 1998 Jan;41(1):48-57 PubMed

J Rheumatol. 1987 Feb;14(1):9-11 PubMed

J Clin Invest. 1993 Dec;92(6):2675-82 PubMed

Arthritis Rheum. 1996 Oct;39(10):1677-84 PubMed

Agents Actions. 1989 Jun;27(3-4):344-6 PubMed

Res Exp Med (Berl). 1997;197(2):81-90 PubMed

Arthritis Rheum. 1996 Apr;39(4):643-7 PubMed

J Pharm Pharmacol. 1997 Feb;49(2):213-5 PubMed

Scand J Rheumatol. 2001;30(4):208-12 PubMed

Folia Microbiol (Praha). 2001;46(2):157-60 PubMed

Arthritis Rheum. 1989 Apr;32(4):370-7 PubMed

Arthritis Rheum. 1998 Aug;41(8):1407-10 PubMed

J Rheumatol. 1995 Oct;22(10):1922-8 PubMed

Folia Microbiol (Praha). 2001;46(1):49-52 PubMed

Int J Immunopharmacol. 1983;5(5):455-61 PubMed

Folia Microbiol (Praha). 1999;44(5):513-8 PubMed

Cell Immunol. 1983 Aug;80(1):198-204 PubMed

J Rheumatol. 2001 Jul;28(7):1476-81 PubMed

Folia Microbiol (Praha). 1995;40(6):639-46 PubMed

J Rheumatol. 1997 Oct;24(10):1890-5 PubMed

Folia Microbiol (Praha). 2001;46(4):353-8 PubMed

Life Sci. 1994;54(17):PL285-9 PubMed

Int J Immunopharmacol. 1988;10(6):717-28 PubMed

Immunopharmacology. 1988 May-Jun;15(3):133-42 PubMed

Bratisl Lek Listy. 2000;101(1):51-3 PubMed

Science. 1992 Dec 18;258(5090):1898-902 PubMed

Clin Exp Immunol. 1997 Oct;110(1):72-8 PubMed

J Rheumatol. 1996 Feb;23(2):230-6 PubMed

Arthritis Rheum. 1989 Sep;32(9):1065-73 PubMed

Ann Rheum Dis. 1996 Apr;55(4):237-42 PubMed

J Rheumatol. 1985 Oct;12(5):904-6 PubMed

Rheum Dis Clin North Am. 1997 Nov;23(4):779-96 PubMed

Clin Chem. 1990 Aug;36(8 Pt 1):1440-3 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...